2024

1. ADAMTS13 recovery in acute thrombotic thrombocytopenic purpura after caplacizumab therapy

   Blood, Vol. 143, Núm. 18, pp. 1807-1815

2. Acceptability of Long-Acting Injectable Antiretroviral Treatment for HIV Management: Perspectives of Patients and Physicians in Spain

   AIDS Patient Care and STDs, Vol. 38, Núm. 7, pp. 305-314

3. Corrigendum to “Prolactin and morning cortisol concentrations in antipsychotic naïve first episode psychosis: A systematic review and meta-analysis” [Psychoneuroendocrinology 150 (2023) 106049] (Psychoneuroendocrinology (2023) 150, (S0306453023000276), (10.1016/j.psyneuen.2023.106049))

   Psychoneuroendocrinology

4. Down Syndrome—Basque Alzheimer Initiative (DS-BAI): Clinic-Biological Cohort

   Journal of Clinical Medicine, Vol. 13, Núm. 4

5. Effectiveness Of Tocilizumab In Aortitis And Aneurysms Associated With Giant Cell Arteritis

   European Journal of Internal Medicine

6. Effectiveness of janus kinase inhibitors in relapsing giant cell arteritis in real-world clinical practice and review of the literature

   Arthritis Research and Therapy, Vol. 26, Núm. 1

7. Experience With Bexarotene to Treat Cutaneous T-Cell Lymphomas: A Study of the Spanish Working Group of Cutaneous Lymphomas

   Actas Dermo-Sifiliograficas, Vol. 115, Núm. 6, pp. 547-554

8. Extending the phenotypic spectrum assessed by the CDR plus NACC FTLD in genetic frontotemporal dementia

   Alzheimer's and Dementia: Diagnosis, Assessment and Disease Monitoring, Vol. 16, Núm. 2

9. Haemoglobinopathies and other rare anemias in Spain: ten years of a nationwide registry (REHem-AR)

   Annals of Hematology, Vol. 103, Núm. 8, pp. 2743-2755

10. Impaired glymphatic system in genetic frontotemporal dementia: a GENFI study

    Brain Communications, Vol. 6, Núm. 4

11. Incidence and clinical manifestations of giant cell arteritis in Spain: results of the ARTESER register

    RMD open, Vol. 10, Núm. 1

12. Incidence and outcoMes of MInor stroke and high-risk traNsient ischEmic attack in NordicTus. IMMINENT study

    Neurologia

13. Long-term benefit of ustekinumab in ulcerative colitis in clinical practice: ULISES study

    Alimentary Pharmacology and Therapeutics

14. Longitudinal cerebral perfusion in presymptomatic genetic frontotemporal dementia: GENFI results

    Alzheimer's and Dementia, Vol. 20, Núm. 5, pp. 3525-3542

15. Prevalence of potentially inappropriate medications and prescription dynamics in elderly hospitalized patients in Spain

    BMC Geriatrics, Vol. 24, Núm. 1

16. Response, complications and risk of leukemic transformation of phosphorus-32 treatment in Philadelphia-negative chronic myeloproliferative syndromes

    Revista Espanola de Medicina Nuclear e Imagen Molecular

17. Subcutaneous vs intravenous abatacept in rheumatoid arthritis-interstitial lung disease. National multicentre study of 397 patients

    Seminars in Arthritis and Rheumatism, Vol. 68

18. The S-REAL study: Spanish real-world data on unresectable stage III NSCLC patients treated with durvalumab after chemoradiotherapy

    Clinical and Translational Oncology, Vol. 26, Núm. 7, pp. 1779-1789

19. Trends in Targeted Therapy Usage in Inflammatory Bowel Disease: TRENDY Study of ENEIDA

    Pharmaceutics, Vol. 16, Núm. 5

20. Umbrella Review: Atlas of the Meta-Analytical Evidence of Early-Onset Psychosis

    Journal of the American Academy of Child and Adolescent Psychiatry, Vol. 63, Núm. 7, pp. 684-697